The influence of mecamylamine on trigeminal and olfactory chemoreception of nicotine

Neuropsychopharmacology

Volumn 31, Issue 2, 2006, Pages 450-461

  Thuerauf, Norbert ^a,b   Markovic, Katrin ^a   Braun, Georg ^a   Bleich, Stefan ^a   Reulbach, Udo ^a   Kornhuber, Johannes ^a   Lunkenheimer, Jens ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Chemoreception; Mecamylamine; Nicotine; Olfaction; Pain; Smell

Indexed keywords

ACETYLCHOLINE; CARBON DIOXIDE; CHOLINERGIC RECEPTOR; MECAMYLAMINE; NICOTINE; PLACEBO;

ACETYLCHOLINE RELEASE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ENANTIOMER; ETHMOID SINUS; FEMALE; HUMAN; MALE; OLFACTORY CORTEX; OLFACTORY DISCRIMINATION; OLFACTORY EPITHELIUM; OLFACTORY RECEPTOR; OLFACTORY TRACT; PRIORITY JOURNAL; SMELLING; TRIGEMINAL NUCLEUS;

ADOLESCENT; ADULT; CHEMORECEPTORS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; EVOKED POTENTIALS; HUMANS; MECAMYLAMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NICOTINE; NICOTINIC ANTAGONISTS; OLFACTORY MUCOSA; PAIN MEASUREMENT; SENSORY THRESHOLDS; STEREOISOMERISM; STIMULATION, CHEMICAL; TRIGEMINAL NERVE;

EID: 30944463237     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300842     Document Type: Article

References (37)

1. Alimohammadi H, Silver WL (2000). Evidence for nicotinic acetylcholine receptors on nasal trigeminal nerve endings of the rat. Chem Senses 25: 61-66.
2. American Psychiatric Association (1996). Practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry 153: 1-31.
3. Cepeda Benito A (1993). Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 61: 822-830.
4. Davies HM, Vaught A (1990). Research Cigarettes. University of Kentucky Printing Services: Kentucky.
5. Dessirier JM, O'Mahony M, Sieffermann JM, Carstens E (1998). Mecamylamine inhibits nicotine but not capsaicin irritation on the tongue: psychophysical evidence that nicotine and capsaicin activate separate molecular receptors. Neurosci Lett 240: 65-68.
6. Dravnieks A, Masurat T, Lamm RA (1984). Hedonics of odors and odor descriptors. J Air Pollution Control Assoc 34: 752-755.
7. Eccles R, Jawad MS, Morris S (1989). Olfactory and trigeminal thresholds and nasal resistance to airflow. Acta Otolaryngol Stockh 108: 268-273.
8. Finger TE, Bottger B, Hansen A, Anderson KT, Alimohammadi H, Silver WL (2003). Solitary chemoreceptor cells in the nasal cavity serve as sentinels of respiration. Proc Natl Acad Sci USA 100: 8981-8986.
9. Grusser SM, Heinz A, Flor H (2000). Standardized stimuli to assess drug craving and drug memory in addicts. J Neural Transm 107: 715-720.
10. Handwerker HO, Kobal G (1993). Psychophysiology of experimentally induced pain. Physiol Rev 73: 639-671.
11. Hilberg O, Jackson AC, Swift DL, Pedersen OF (1989). Acoustic rhinometry: evaluation of nasal cavity geometry by acoustic reflection. J Appl Physiol 66: 295-303.
12. Hummel T, Hummel C, Pauli E, Kobal G (1992a). Olfactory discrimination of nicotine-enantiomers by smokers and nonsmokers. Chem Senses 17: 13-21.
13. Hummel T, Livermore A, Hummel C, Kobal G (1992b). Chemosensory event-related potentials in man: relation to olfactory and painful sensations elicited by nicotine. Electroencephalogr Clin Neurophysiol 84: 192-195.
14. Hummel T, Schiessl C, Wendler J, Kobal G (1996). Peripheral electrophysiological responses decrease in response to repetitive painful stimulation of the human nasal mucosa. Neurosci Lett 212: 37-40.
15. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997). Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22: 39-52.
16. Kobal G (1985). Pain-related electrical potentials of the human nasal mucosa elicited by chemical stimulation. Pain 22: 151-163.
17. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G (1995). Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 24: 41-47.
18. Laviolette SR, van der Kooy D (2004). The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci 5: 55-65.
19. Menini A, Picco C, Firestein S (1995). Quantal-like current fluctuations induced by odorants in olfactory receptor cells (see comments). Nature 373: 435-437.
20. Papke RL, Sanberg PR, Shytle RD (2001). Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther 297: 646-656.
21. Renner B, Meindorfner F, Kaegler M, Thuerauf N, Barocka A, Kobal G (1998). Discrimination of R- and S-nicotine by the trigeminal nerve. Chem Senses 29: 602.
22. Silagy C, Mant D, Fowler G, Lodge M (1994). Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139-142.
23. Stein C, Mendl G (1988). The German counterpart to McGill Pain Questionnaire. Pain 32: 251-255.
24. Sutherland G, Stapleton JA, Russell MA, Jarvis MJ, Hajek P, Belcher M et al (1992). Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340: 324-329.
25. 2 in rats: is it a peripheral nociceptive event? Neurosci Lett 128: 297-300.
26. 2. Brain Res 942: 79-86.
27. Thuerauf N, Hummel T, Kettenmann B, Kobal G (1993). Nociceptive and reflexive responses recorded from the human nasal mucosa. Brain Res 629: 293-299.
28. Thuerauf N, Kaegler M, Dietz R, Barocka A, Kobal G (1999). Dose-dependent stereoselective activation of the trigeminal sensory system by nicotine in man. Psychopharmacology 142: 236-243.
29. Thuerauf N, Kaegler M, Renner B, Barocka A, Kobal G (2000). Specific sensory detection, discrimination, and Hedonic estimation of nicotine enantiomers in smokers and nonsmokers: are there limitations in replacing the sensory components in nicotine. J Clin Psychopharmacol 20: 472-478.
30. Thuerauf N, Renner B, Kobal G (1995). Responses recorded from the frog olfactory epithelium after stimulation with R(+)- and S(-)-nicotine. Chem Senses 20: 337-344.
31. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F (1993). A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 269: 1268-1271.
32. Walker JC, Kendal-Reed M, Keiger CJ, Bencherif M, Silver WL (1996). Olfactory and trigeminal responses to nicotine. Drug Dev Res 38: 160-168.
33. Westman EC, Behm FM, Rose JE (1995). Airway sensory replacement combined with nicotine replacement for smoking cessation: a randomized, placebo controlled trial using a citric acid inhaler. Chest 107: 1358-1364.
34. Westman EC, Behm FM, Rose JE (1996). Dissociating the nicotine and airway sensory effects of smoking. Pharmacol Biochem Behav 53: 309-315.
35. Woodruff-Pak DS (2003). Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning. Behav Brain Res 143: 159-167.
36. Wysocki CJ, Beauchamp GK (1984). Ability to smell androstenone is genetically determined. Proc Natl Acad Sci USA 81: 4899-4902.
37. Zattore RJ, Jones-Gotman M (1990). Right-nostril advantage for discrimination of odors. Percept Psychophys 47: 526-531.